Condition: Multiple Sclerosis (MS) · Sponsor: University Hospital, Strasbourg, France
The objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group). The investigators also aim to identify factors associated with inflammatory relapse and treatment-related complications.
This description comes directly from the study's public registry record.
Nicolas Collongues, MD · 33 3.88.12.87.33 · nicolas.collongues@chru-strasbourg.fr
Always discuss trial participation with your own doctor first.
| Centre d'Investigation Clinique - CHU de Strasbourg - France | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07313462